tiprankstipranks
Neoleukin Therapeutics announces 1-for-5 reverse stock split
PremiumThe FlyNeoleukin Therapeutics announces 1-for-5 reverse stock split
7M ago
Is NLTX a Buy, Before Earnings?
PremiumPre-Earnings
Is NLTX a Buy, Before Earnings?
8M ago
Neoleukin Therapeutics and Neurogene announce definitive merger agreement
PremiumThe Fly
Neoleukin Therapeutics and Neurogene announce definitive merger agreement
9M ago
Neoleukin Therapeutics downgraded to Neutral from Buy at Guggenheim
PremiumThe FlyNeoleukin Therapeutics downgraded to Neutral from Buy at Guggenheim
1y ago
Neoleukin Therapeutics presents preclinical data on NEO-TRA1 at ASH
PremiumThe Fly
Neoleukin Therapeutics presents preclinical data on NEO-TRA1 at ASH
1y ago
Neoleukin Therapeutics Presents Preclinical Data on NEO-TRA1 at American Society of Hematology (ASH) Annual Meeting
PremiumPress Releases
Neoleukin Therapeutics Presents Preclinical Data on NEO-TRA1 at American Society of Hematology (ASH) Annual Meeting
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100